Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ESMO Asia 2023

01–03 December 2023 | Singapore, Singapore

ESMO Asia 2023

01–03 December 2023 | Singapore, Singapore
The role of immunotherapies in advanced acral and mucosal melanoma 3:00
The role of immunotherapies in advanced acral and mucosal melanoma
Karijn Suijkerbuijk • 28 Nov 2023
Novel imaging technologies for cancer diagnosis and management 4:10
Novel imaging technologies for cancer diagnosis and management
Sola Adeleke • 8 Dec 2023
Challenges in the implementation of novel cancer imaging techniques 1:19
Challenges in the implementation of novel cancer imaging techniques
Sola Adeleke • 8 Dec 2023
Immunotherapy in gynecological cancers 1:07
Immunotherapy in gynecological cancers
Sola Adeleke • 8 Dec 2023
EGFR mutations increase recurrence in NSCLC 2:57
EGFR mutations increase recurrence in NSCLC
Masahiro Tsuboi • 11 Dec 2023
Alectinib for the treatment of NSCLC: an update on the ALINA trial 2:37
Alectinib for the treatment of NSCLC: an update on the ALINA trial
Masahiro Tsuboi • 11 Dec 2023
Challenges managing treatment related adverse events in acral and mucosal melanomas 2:44
Challenges managing treatment related adverse events in acral and mucosal melanomas
Karijn Suijkerbuijk • 28 Nov 2023
New biomarker imaging techniques to improve MK-2206 efficacy in breast cancer 1:39
New biomarker imaging techniques to improve MK-2206 efficacy in breast cancer
Jiang Zhang • 24 Nov 2023
Predicting MK-2206 response in patients with breast cancer 1:19
Predicting MK-2206 response in patients with breast cancer
Jiang Zhang • 24 Nov 2023
Next steps in utilizing DCE-MRI to predict MK-2206 response in breast cancer 0:59
Next steps in utilizing DCE-MRI to predict MK-2206 response in breast cancer
Jiang Zhang • 24 Nov 2023
How molecular stratification can guide treatment of upper airway cancers and SCC 5:04
How molecular stratification can guide treatment of upper airway cancers and SCC
Brian Henick • 6 Dec 2023
The role of immunotherapy in PD-L1 low advanced squamous cell carcinoma 0:54
The role of immunotherapy in PD-L1 low advanced squamous cell carcinoma
Brian Henick • 6 Dec 2023
The future of squamous cell carcinoma research at ESMO Asia 2023 1:40
The future of squamous cell carcinoma research at ESMO Asia 2023
Brian Henick • 6 Dec 2023
The clinical use of ctDNA as a biomarker in TNBC 1:53
The clinical use of ctDNA as a biomarker in TNBC
Michail Ignatiadis • 22 Nov 2023
Teslisotuzumab vedotin and osimertinib for EGFR-mutant, c-Met-overexpressing NSCLC 3:54
Teslisotuzumab vedotin and osimertinib for EGFR-mutant, c-Met-overexpressing NSCLC
Hidehito Horinouchi • 11 Dec 2023
The clinical use of tyrosine kinase inhibitors in EGFR-mutant NSCLC 6:15
The clinical use of tyrosine kinase inhibitors in EGFR-mutant NSCLC
Masahiro Tsuboi • 11 Dec 2023
The content of VJOncology is intended for healthcare professionals